SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-034627
Filing Date
2016-12-01
Accepted
2016-12-01 14:27:12
Documents
1
Period of Report
2016-11-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8220
  Complete submission text file 0000899243-16-034627.txt   10310
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 203-855-0400
Canaan IX L.P. (Reporting) CIK: 0001538676 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 162027845

Mailing Address 2765 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2765 SAND HILL ROAD MENLO PARK CA 94025 6508548092
Canaan Partners IX LLC (Reporting) CIK: 0001654586 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 162027844